Global Expectorant Drug Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032408338

Publication Date:

March 18, 2024

Pages:

169

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Expectorant Drug market size is expected to reach $ 524.2 million by 2030, rising at a market growth of 6.6% CAGR during the forecast period (2024-2030).
Growing Respiratory Disorders: With increasing pollution levels, smoking habits, and respiratory infections, the prevalence of respiratory disorders such as bronchitis, COPD (Chronic Obstructive Pulmonary Disease), and asthma is rising globally. This drives the demand for expectorant drugs as they help in clearing mucus from the respiratory tract.Preference for Natural Remedies: There's a growing trend towards natural and herbal expectorants as people become more health-conscious and seek alternatives to conventional medication. This trend might impact the market share of synthetic expectorants.Technological Advancements: Pharmaceutical companies are continuously investing in research and development to introduce more effective and safer expectorant formulations. This includes innovations in drug delivery systems to enhance the efficacy and convenience of expectorant medications.
This report studies the global Expectorant Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Expectorant Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Expectorant Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Expectorant Drug total production and demand, 2019-2030, (K Units)
Global Expectorant Drug total production value, 2019-2030, (USD Million)
Global Expectorant Drug production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Expectorant Drug domestic production, consumption, key domestic manufacturers and share
Global Expectorant Drug production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Expectorant Drug production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Expectorant Drug production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Expectorant Drug market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Acella Pharmaceuticals LLC, Astrazeneca Plc., Cipla Limited, Dabur India Ltd, Glenmark Pharmaceuticals Limited, lohnson and Johnson, Merck KGaA and Novartis International AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Expectorant Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Expectorant Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Expectorant Drug Market, Segmentation by Type
Oral Solid
Oral Liquid
Inhalants
Global Expectorant Drug Market, Segmentation by Application
Hospital
Clinic
Other
Companies Profiled:
Abbott Laboratories
Acella Pharmaceuticals LLC
Astrazeneca Plc.
Cipla Limited
Dabur India Ltd
Glenmark Pharmaceuticals Limited
lohnson and Johnson
Merck KGaA
Novartis International AG
Pfizer Inc.
Proctor and Gamble Co
Reckitt Benckiser Group plc
Sanofi SA
The Himalaya Drug Company
Perrigo Company plc
Vernalis plc
Tris Pharma Inc.
Aytu BioScience Inc.
Mayne Pharma Inc.
Taro Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC
Aurobindo Pharma Ltd
GlaxoSmithKline plc.
Key Questions Answered
1. How big is the global Expectorant Drug market?
2. What is the demand of the global Expectorant Drug market?
3. What is the year over year growth of the global Expectorant Drug market?
4. What is the production and production value of the global Expectorant Drug market?
5. Who are the key producers in the global Expectorant Drug market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Expectorant Drug Introduction
1.2 World Expectorant Drug Supply & Forecast
1.2.1 World Expectorant Drug Production Value (2019 & 2023 & 2030)
1.2.2 World Expectorant Drug Production (2019-2030)
1.2.3 World Expectorant Drug Pricing Trends (2019-2030)
1.3 World Expectorant Drug Production by Region (Based on Production Site)
1.3.1 World Expectorant Drug Production Value by Region (2019-2030)
1.3.2 World Expectorant Drug Production by Region (2019-2030)
1.3.3 World Expectorant Drug Average Price by Region (2019-2030)
1.3.4 North America Expectorant Drug Production (2019-2030)
1.3.5 Europe Expectorant Drug Production (2019-2030)
1.3.6 China Expectorant Drug Production (2019-2030)
1.3.7 Japan Expectorant Drug Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Expectorant Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Expectorant Drug Major Market Trends
2 Demand Summary
2.1 World Expectorant Drug Demand (2019-2030)
2.2 World Expectorant Drug Consumption by Region
2.2.1 World Expectorant Drug Consumption by Region (2019-2024)
2.2.2 World Expectorant Drug Consumption Forecast by Region (2025-2030)
2.3 United States Expectorant Drug Consumption (2019-2030)
2.4 China Expectorant Drug Consumption (2019-2030)
2.5 Europe Expectorant Drug Consumption (2019-2030)
2.6 Japan Expectorant Drug Consumption (2019-2030)
2.7 South Korea Expectorant Drug Consumption (2019-2030)
2.8 ASEAN Expectorant Drug Consumption (2019-2030)
2.9 India Expectorant Drug Consumption (2019-2030)
3 World Expectorant Drug Manufacturers Competitive Analysis
3.1 World Expectorant Drug Production Value by Manufacturer (2019-2024)
3.2 World Expectorant Drug Production by Manufacturer (2019-2024)
3.3 World Expectorant Drug Average Price by Manufacturer (2019-2024)
3.4 Expectorant Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Expectorant Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Expectorant Drug in 2023
3.5.3 Global Concentration Ratios (CR8) for Expectorant Drug in 2023
3.6 Expectorant Drug Market: Overall Company Footprint Analysis
3.6.1 Expectorant Drug Market: Region Footprint
3.6.2 Expectorant Drug Market: Company Product Type Footprint
3.6.3 Expectorant Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Expectorant Drug Production Value Comparison
4.1.1 United States VS China: Expectorant Drug Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Expectorant Drug Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Expectorant Drug Production Comparison
4.2.1 United States VS China: Expectorant Drug Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Expectorant Drug Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Expectorant Drug Consumption Comparison
4.3.1 United States VS China: Expectorant Drug Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Expectorant Drug Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Expectorant Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.4.3 United States Based Manufacturers Expectorant Drug Production (2019-2024)
4.5 China Based Expectorant Drug Manufacturers and Market Share
4.5.1 China Based Expectorant Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.5.3 China Based Manufacturers Expectorant Drug Production (2019-2024)
4.6 Rest of World Based Expectorant Drug Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Expectorant Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Expectorant Drug Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Expectorant Drug Production (2019-2024)
5 Market Analysis by Type
5.1 World Expectorant Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral Solid
5.2.2 Oral Liquid
5.2.3 Inhalants
5.3 Market Segment by Type
5.3.1 World Expectorant Drug Production by Type (2019-2030)
5.3.2 World Expectorant Drug Production Value by Type (2019-2030)
5.3.3 World Expectorant Drug Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World Expectorant Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Expectorant Drug Production by Application (2019-2030)
6.3.2 World Expectorant Drug Production Value by Application (2019-2030)
6.3.3 World Expectorant Drug Average Price by Application (2019-2030)
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Details
7.1.2 Abbott Laboratories Major Business
7.1.3 Abbott Laboratories Expectorant Drug Product and Services
7.1.4 Abbott Laboratories Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Laboratories Recent Developments/Updates
7.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.2 Acella Pharmaceuticals LLC
7.2.1 Acella Pharmaceuticals LLC Details
7.2.2 Acella Pharmaceuticals LLC Major Business
7.2.3 Acella Pharmaceuticals LLC Expectorant Drug Product and Services
7.2.4 Acella Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Acella Pharmaceuticals LLC Recent Developments/Updates
7.2.6 Acella Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.3 Astrazeneca Plc.
7.3.1 Astrazeneca Plc. Details
7.3.2 Astrazeneca Plc. Major Business
7.3.3 Astrazeneca Plc. Expectorant Drug Product and Services
7.3.4 Astrazeneca Plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Astrazeneca Plc. Recent Developments/Updates
7.3.6 Astrazeneca Plc. Competitive Strengths & Weaknesses
7.4 Cipla Limited
7.4.1 Cipla Limited Details
7.4.2 Cipla Limited Major Business
7.4.3 Cipla Limited Expectorant Drug Product and Services
7.4.4 Cipla Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Cipla Limited Recent Developments/Updates
7.4.6 Cipla Limited Competitive Strengths & Weaknesses
7.5 Dabur India Ltd
7.5.1 Dabur India Ltd Details
7.5.2 Dabur India Ltd Major Business
7.5.3 Dabur India Ltd Expectorant Drug Product and Services
7.5.4 Dabur India Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Dabur India Ltd Recent Developments/Updates
7.5.6 Dabur India Ltd Competitive Strengths & Weaknesses
7.6 Glenmark Pharmaceuticals Limited
7.6.1 Glenmark Pharmaceuticals Limited Details
7.6.2 Glenmark Pharmaceuticals Limited Major Business
7.6.3 Glenmark Pharmaceuticals Limited Expectorant Drug Product and Services
7.6.4 Glenmark Pharmaceuticals Limited Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
7.6.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
7.7 lohnson and Johnson
7.7.1 lohnson and Johnson Details
7.7.2 lohnson and Johnson Major Business
7.7.3 lohnson and Johnson Expectorant Drug Product and Services
7.7.4 lohnson and Johnson Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 lohnson and Johnson Recent Developments/Updates
7.7.6 lohnson and Johnson Competitive Strengths & Weaknesses
7.8 Merck KGaA
7.8.1 Merck KGaA Details
7.8.2 Merck KGaA Major Business
7.8.3 Merck KGaA Expectorant Drug Product and Services
7.8.4 Merck KGaA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Merck KGaA Recent Developments/Updates
7.8.6 Merck KGaA Competitive Strengths & Weaknesses
7.9 Novartis International AG
7.9.1 Novartis International AG Details
7.9.2 Novartis International AG Major Business
7.9.3 Novartis International AG Expectorant Drug Product and Services
7.9.4 Novartis International AG Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Novartis International AG Recent Developments/Updates
7.9.6 Novartis International AG Competitive Strengths & Weaknesses
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Details
7.10.2 Pfizer Inc. Major Business
7.10.3 Pfizer Inc. Expectorant Drug Product and Services
7.10.4 Pfizer Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Pfizer Inc. Recent Developments/Updates
7.10.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.11 Proctor and Gamble Co
7.11.1 Proctor and Gamble Co Details
7.11.2 Proctor and Gamble Co Major Business
7.11.3 Proctor and Gamble Co Expectorant Drug Product and Services
7.11.4 Proctor and Gamble Co Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Proctor and Gamble Co Recent Developments/Updates
7.11.6 Proctor and Gamble Co Competitive Strengths & Weaknesses
7.12 Reckitt Benckiser Group plc
7.12.1 Reckitt Benckiser Group plc Details
7.12.2 Reckitt Benckiser Group plc Major Business
7.12.3 Reckitt Benckiser Group plc Expectorant Drug Product and Services
7.12.4 Reckitt Benckiser Group plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Reckitt Benckiser Group plc Recent Developments/Updates
7.12.6 Reckitt Benckiser Group plc Competitive Strengths & Weaknesses
7.13 Sanofi SA
7.13.1 Sanofi SA Details
7.13.2 Sanofi SA Major Business
7.13.3 Sanofi SA Expectorant Drug Product and Services
7.13.4 Sanofi SA Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Sanofi SA Recent Developments/Updates
7.13.6 Sanofi SA Competitive Strengths & Weaknesses
7.14 The Himalaya Drug Company
7.14.1 The Himalaya Drug Company Details
7.14.2 The Himalaya Drug Company Major Business
7.14.3 The Himalaya Drug Company Expectorant Drug Product and Services
7.14.4 The Himalaya Drug Company Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 The Himalaya Drug Company Recent Developments/Updates
7.14.6 The Himalaya Drug Company Competitive Strengths & Weaknesses
7.15 Perrigo Company plc
7.15.1 Perrigo Company plc Details
7.15.2 Perrigo Company plc Major Business
7.15.3 Perrigo Company plc Expectorant Drug Product and Services
7.15.4 Perrigo Company plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Perrigo Company plc Recent Developments/Updates
7.15.6 Perrigo Company plc Competitive Strengths & Weaknesses
7.16 Vernalis plc
7.16.1 Vernalis plc Details
7.16.2 Vernalis plc Major Business
7.16.3 Vernalis plc Expectorant Drug Product and Services
7.16.4 Vernalis plc Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.16.5 Vernalis plc Recent Developments/Updates
7.16.6 Vernalis plc Competitive Strengths & Weaknesses
7.17 Tris Pharma Inc.
7.17.1 Tris Pharma Inc. Details
7.17.2 Tris Pharma Inc. Major Business
7.17.3 Tris Pharma Inc. Expectorant Drug Product and Services
7.17.4 Tris Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.17.5 Tris Pharma Inc. Recent Developments/Updates
7.17.6 Tris Pharma Inc. Competitive Strengths & Weaknesses
7.18 Aytu BioScience Inc.
7.18.1 Aytu BioScience Inc. Details
7.18.2 Aytu BioScience Inc. Major Business
7.18.3 Aytu BioScience Inc. Expectorant Drug Product and Services
7.18.4 Aytu BioScience Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.18.5 Aytu BioScience Inc. Recent Developments/Updates
7.18.6 Aytu BioScience Inc. Competitive Strengths & Weaknesses
7.19 Mayne Pharma Inc.
7.19.1 Mayne Pharma Inc. Details
7.19.2 Mayne Pharma Inc. Major Business
7.19.3 Mayne Pharma Inc. Expectorant Drug Product and Services
7.19.4 Mayne Pharma Inc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.19.5 Mayne Pharma Inc. Recent Developments/Updates
7.19.6 Mayne Pharma Inc. Competitive Strengths & Weaknesses
7.20 Taro Pharmaceutical Industries Ltd.
7.20.1 Taro Pharmaceutical Industries Ltd. Details
7.20.2 Taro Pharmaceutical Industries Ltd. Major Business
7.20.3 Taro Pharmaceutical Industries Ltd. Expectorant Drug Product and Services
7.20.4 Taro Pharmaceutical Industries Ltd. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.20.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
7.20.6 Taro Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.21 Amneal Pharmaceuticals LLC
7.21.1 Amneal Pharmaceuticals LLC Details
7.21.2 Amneal Pharmaceuticals LLC Major Business
7.21.3 Amneal Pharmaceuticals LLC Expectorant Drug Product and Services
7.21.4 Amneal Pharmaceuticals LLC Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.21.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.21.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.22 Aurobindo Pharma Ltd
7.22.1 Aurobindo Pharma Ltd Details
7.22.2 Aurobindo Pharma Ltd Major Business
7.22.3 Aurobindo Pharma Ltd Expectorant Drug Product and Services
7.22.4 Aurobindo Pharma Ltd Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.22.5 Aurobindo Pharma Ltd Recent Developments/Updates
7.22.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
7.23 GlaxoSmithKline plc.
7.23.1 GlaxoSmithKline plc. Details
7.23.2 GlaxoSmithKline plc. Major Business
7.23.3 GlaxoSmithKline plc. Expectorant Drug Product and Services
7.23.4 GlaxoSmithKline plc. Expectorant Drug Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.23.5 GlaxoSmithKline plc. Recent Developments/Updates
7.23.6 GlaxoSmithKline plc. Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Expectorant Drug Industry Chain
8.2 Expectorant Drug Upstream Analysis
8.2.1 Expectorant Drug Core Raw Materials
8.2.2 Main Manufacturers of Expectorant Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Expectorant Drug Production Mode
8.6 Expectorant Drug Procurement Model
8.7 Expectorant Drug Industry Sales Model and Sales Channels
8.7.1 Expectorant Drug Sales Model
8.7.2 Expectorant Drug Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Acella Pharmaceuticals LLC
Astrazeneca Plc.
Cipla Limited
Dabur India Ltd
Glenmark Pharmaceuticals Limited
lohnson and Johnson
Merck KGaA
Novartis International AG
Pfizer Inc.
Proctor and Gamble Co
Reckitt Benckiser Group plc
Sanofi SA
The Himalaya Drug Company
Perrigo Company plc
Vernalis plc
Tris Pharma Inc.
Aytu BioScience Inc.
Mayne Pharma Inc.
Taro Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC
Aurobindo Pharma Ltd
GlaxoSmithKline plc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂